Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00258336
Status:
UNKNOWN
Last Update Posted:
2014-01-10
First Post:
2005-11-22
Brief Title:
Rituximab Vaccine Therapy and GM-CSF in Treating Patients With Non-Hodgkins Lymphoma
Sponsor:
Favrille
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |
Keywords:
| Name | View |
|---|---|
| stage I grade 2 follicular lymphoma | View |
| recurrent grade 1 follicular lymphoma | View |
| recurrent grade 2 follicular lymphoma | View |
| stage III grade 1 follicular lymphoma | View |
| stage III grade 2 follicular lymphoma | View |
| stage IV grade 1 follicular lymphoma | View |
| stage IV grade 2 follicular lymphoma | View |
| contiguous stage II grade 1 follicular lymphoma | View |
| contiguous stage II grade 2 follicular lymphoma | View |
| noncontiguous stage II grade 1 follicular lymphoma | View |
| noncontiguous stage II grade 2 follicular lymphoma | View |
| stage I grade 1 follicular lymphoma | View |